Sign in to continue:

Friday, April 24th, 2026

zSpace, Inc. Receives Nasdaq Non-Compliance Notice and Plans Appeal – Form 8-K Filing April 2026

zSpace, Inc. Receives Nasdaq Delisting Notice: Key Shareholder Implications

zSpace, Inc. (Nasdaq: ZSPC) has announced, via a recent SEC Form 8-K filing, that it has received a written notification from the Listing Qualifications Department (“Staff”) of The Nasdaq Stock Market LLC regarding its non-compliance with a critical continued listing requirement. This development is significant for shareholders and may impact zSpace’s stock price and trading status.

Key Points from the Report

  • Delisting Notice: zSpace received the Nasdaq notice on December 11, 2025, informing the company that it is not in compliance with Nasdaq’s continued listing rule, specifically relating to the minimum closing bid price requirement.
  • Bid Price Violation: The company has failed to maintain a closing bid price greater than \$0.10, as required by Nasdaq Listing Rule 5810(c)(3)(A)(iii).
  • Appeal Process: zSpace intends to submit an appeal to Nasdaq by or before 4:00 p.m. Eastern Time on April 28, 2026, pursuant to Listing Rule 5815(a)(1)(B)(ii)(e). However, a timely request for a hearing will not prevent the suspension of trading in zSpace’s securities for failing to meet the minimum bid price requirement.
  • Effect of Hearing Request: While a timely hearing request will stay the filing of Form 25-NSE and the removal of zSpace’s securities from Nasdaq Capital Market listing and registration pending the Panel’s decision, trading suspension will proceed regardless.
  • No Guarantee of Favorable Outcome: The company clearly states that no assurances can be provided that zSpace will obtain a favorable decision from the Panel.
  • Disclosure Compliance: This 8-K filing is made in accordance with Nasdaq Listing Rule 5810(b), which requires public disclosure of receipt of a delisting notification.

Shareholder Considerations & Potential Price Sensitivity

  • Trading Suspension Risk: If zSpace fails to win its appeal, or if the hearing process does not result in a favorable outcome, trading in ZSPC shares may be suspended and the shares may be delisted from Nasdaq. This could significantly impact liquidity, marketability, and potentially the value of zSpace’s shares.
  • Forward-Looking Statements: The company warns that its forward-looking statements regarding the appeal, compliance, and potential relief from delisting are subject to risks, uncertainties, and may not materialize. These include the possibility that zSpace may not meet Nasdaq requirements during any compliance period or in the future, and that Nasdaq may not grant relief or allow the company to remain listed.
  • Risk Factors: Shareholders are advised to review risk factors disclosed in zSpace’s 2025 Annual Report (Form 10-K) and other SEC filings for additional context on listing risks and company performance.
  • Emerging Growth Company Status: zSpace identifies as an emerging growth company, which may affect its reporting and compliance obligations.

Other Notable Details

  • Security Details: The affected security is zSpace’s common stock, par value \$0.00001 per share, trading under the symbol ZSPC on Nasdaq.
  • Corporate Address: zSpace, Inc., 2050 Gateway Place, Suite 100-302, San Jose, CA 95110.
  • Chief Financial Officer: The filing is signed by Erick DeOliveira, CFO of zSpace, Inc.

Potential Impact on Share Price

  • The risk of delisting and trading suspension is highly price-sensitive: If trading is suspended or shares are delisted, it may result in a sharp decline in share price, reduced investor confidence, and limited ability to sell or buy shares in the open market.
  • Uncertainty remains: The outcome of the appeal process is unknown. Investors should be prepared for possible volatility and further developments as zSpace pursues its appeal.

Disclaimer

This article is based on information disclosed in zSpace, Inc.’s SEC Form 8-K filing dated April 23, 2026. It contains forward-looking statements subject to risks and uncertainties. Shareholders and prospective investors should refer to official SEC filings, consult with financial advisors, and consider their own risk tolerance before making investment decisions. This is not investment advice.

View zSpace, Inc. Historical chart here



OS Therapies Inc: Advancing Osteosarcoma Treatment with OST-HER2 Immunotherapy and Next-Generation Oncology Pipeline

OS Therapies Inc (OSTX) 2025 Annual Report – Key Investor Hi...

Worthington Steel, Inc. 2026 Q3 SEC 10-Q Report: Financial Statements, Company Overview, and Key Disclosures

Worthington Steel, Inc. Q3 2026 Financial Report – Key Inves...

   Ad

Join Our Investing Seminar

Limited seats available — Reserve your spot today